Mega Lifesciences PCL
SET:MEGA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Mega Lifesciences PCL
SET:MEGA
|
TH |
|
Anfield Energy Inc
XTSX:AEC
|
CA |
|
Antero Midstream Corp
NYSE:AM
|
US |
|
Plant Health Care PLC
LSE:PHC
|
US |
|
Journey Medical Corp
NASDAQ:DERM
|
US |
|
B
|
Brunswick Corp
SWB:BWI
|
US |
|
Cognex Corp
NASDAQ:CGNX
|
US |
|
Bureau Veritas SA
PAR:BVI
|
FR |
|
Genuine Parts Co
NYSE:GPC
|
US |
|
Evolution Mining Ltd
ASX:EVN
|
AU |
|
M
|
Mediwound Ltd
F:M8W
|
IL |
|
Vertiv Holdings Co
NYSE:VRT
|
US |
|
J
|
Jardine Matheson Holdings Ltd
LSE:JAR
|
HK |
|
Mhp Se
LSE:MHPC
|
UA |
|
Medical Data Vision Co Ltd
TSE:3902
|
JP |
|
E
|
Evoke Pharma Inc
F:EV0
|
US |
|
S
|
Savills PLC
F:1YZ
|
UK |
|
T
|
T-Mobile US Inc
LSE:0R2L
|
US |
Mega Lifesciences PCL
Mega Lifesciences PCL makes and sells health products, especially vitamins, dietary supplements, and over-the-counter medicines. It also helps other consumer health brands package, distribute, and market their products in different countries, so it sits between manufacturers, pharmacies, and consumers in the healthcare supply chain. The company sells to pharmacies, drugstores, hospitals, clinics, and distributors, while some products reach consumers through retail channels. It earns money by manufacturing its own brands, supplying finished health products to partners, and charging for distribution and brand support services in markets where it has local sales networks. What makes Mega different is its role as both a brand owner and a regional distribution partner. That gives it a business model built around trusted health products, local market access, and regulatory know-how, which matters in a field where ingredients, labeling, and approval rules are tightly controlled.
Mega Lifesciences PCL makes and sells health products, especially vitamins, dietary supplements, and over-the-counter medicines. It also helps other consumer health brands package, distribute, and market their products in different countries, so it sits between manufacturers, pharmacies, and consumers in the healthcare supply chain.
The company sells to pharmacies, drugstores, hospitals, clinics, and distributors, while some products reach consumers through retail channels. It earns money by manufacturing its own brands, supplying finished health products to partners, and charging for distribution and brand support services in markets where it has local sales networks.
What makes Mega different is its role as both a brand owner and a regional distribution partner. That gives it a business model built around trusted health products, local market access, and regulatory know-how, which matters in a field where ingredients, labeling, and approval rules are tightly controlled.
